Morgan Stanley downgraded UBS (UBS) to Underweight from Equal Weight with a price target of CHF 26, down from CHF 28. The firm downgraded shares after taking a “first stab” at incorporating the new capital proposal in its numbers. Morgan Stanley sees potential for “several mitigating actions,” but expects uncertainty and the capital headwind to continue to weigh on the share price for the foreseeable future. The analyst lowered buyback assumptions to $3B from 2026 onwards.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UBS:
- Cautious Outlook on UBS Group AG: Sell Rating Amid Capital Concerns and EPS Adjustments
- UBS Reiterates Buy Rating on Eli Lilly Stock (LLY) and Lauds Pricing Strategy
- UBS price target raised to CHF 27.60 from CHF 26.90 at Citi
- EVgo, Uranium Energy, UBS, Pinterest, Block: Trending by Analysts
- UBS ‘strongly disagrees’ with ‘extreme increase’ in capital requirements